Lv52
824 积分 2023-09-03 加入
PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition
9天前
已完结
A High-Content Screening Workflow for Pancreatic Cancer Therapy Development Using Patient-Derived Tumor Organoid Cohorts: An Adaptation to Enable In Organoid Synergistic Drug Discovery
13天前
已完结
Metabolic reprogramming drives pancreatic β cell neogenesis from α cells
29天前
已完结
Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension
29天前
已完结
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
30天前
已完结
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
1个月前
已完结
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS -Mutated Melanoma
2个月前
已完结
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2个月前
已完结
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS -Mutated Melanoma
2个月前
已关闭
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
